Abu-Shakra M, El-Sana S, Margalith M, Sikuler E, Neumann L, Buskila D
Rheumatic Diseases Unit, Faculty of Health Sciences, Soroka Medical Centre and Ben-Gurion University, Beer-Sheva, Israel.
Lupus. 1997;6(6):543-4. doi: 10.1177/096120339700600612.
Sera of 95 patients with SLE were tested for the presence of hepatitis B surface antigen (HBsAg) and anti-hepatitis C antibodies. The results show that HBsAg was not detected in the sera of all of the SLE patients. Only one patient was confirmed to have anti-HCV antibodies, suggesting that chronic infection with hepatitis B and C is not increased in patients with SLE compared with the general population.
对95例系统性红斑狼疮(SLE)患者的血清进行了乙肝表面抗原(HBsAg)和抗丙型肝炎抗体检测。结果显示,所有SLE患者血清中均未检测到HBsAg。仅1例患者被确诊有抗丙型肝炎病毒抗体,这表明与普通人群相比,SLE患者中乙肝和丙肝慢性感染并未增加。